Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2

Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2

Bibliographic Details
Main Authors:	Hong Lei, Aqu Alu, Jingyun Yang, Cai He, Weiqi Hong, Zesheng Cheng, Li Yang, Jiong Li, Zhenling Wang, Wei Wang, Guangwen Lu, Xiawei Wei
Format:	Article
Language:	English
Published:	Nature Publishing Group 2020-12-01
Series:	Signal Transduction and Targeted Therapy
Online Access:	https://doi.org/10.1038/s41392-020-00434-x

Similar Items

Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants
by: Hong Lei, et al.
Published: (2022-05-01)

Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants
by: Hong Lei, et al.
Published: (2023-05-01)

A recombinant spike‐XBB.1.5 protein vaccine induces broad‐spectrum immune responses against XBB.1.5‐included Omicron variants of SARS‐CoV‐2
by: Cai He, et al.
Published: (2023-06-01)

Intranasal boosting with RBD-HR protein vaccine elicits robust mucosal and systemic immune responses
by: Li Chen, et al.
Published: (2024-07-01)

Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection
by: Jingyun Yang, et al.
Published: (2023-06-01)

A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS‐CoV‐2 variants and wild‐type of the virus
by: Cai He, et al.
Published: (2021-09-01)

Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19
by: Yanghong Ni, et al.
Published: (2021-01-01)

BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies
by: Aqu Alu, et al.
Published: (2022-10-01)

Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5‐included SARS‐CoV‐2 variants than homologous vaccination of mRNA vaccine
by: Dandan Peng, et al.
Published: (2023-04-01)

Intranasal COVID-19 vaccines: From bench to bed
by: Aqu Alu, et al.
Published: (2022-02-01)

cGAS-STING pathway in cancer biotherapy
by: Yang Wang, et al.
Published: (2020-09-01)

Spike protein of SARS‐CoV‐2 Omicron (B.1.1.529) variant have a reduced ability to induce the immune response
by: Cai He, et al.
Published: (2022-04-01)

S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis
by: Fei Ye, et al.
Published: (2021-09-01)

Trimeric protein vaccine based on Beta variant elicits robust immune response against BA.4/5-included SARS-CoV-2 Omicron variants
by: Cai He, et al.
Published: (2023-03-01)

The role of lysosome in regulated necrosis
by: Aqu Alu, et al.
Published: (2020-10-01)

Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment
by: Haiying Que, et al.
Published: (2022-12-01)

Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy
by: Xuejiao Han, et al.
Published: (2022-11-01)

SARS‐CoV‐2 Omicron variant: Characteristics and prevention
by: Xuemei He, et al.
Published: (2021-12-01)

An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery
by: Kailash C. Petkar, et al.
Published: (2021-03-01)

Scientific rationale for developing potent RBD-based vaccines targeting COVID-19
by: Harry Kleanthous, et al.
Published: (2021-10-01)

SARS-CoV-2 tetrameric RBD protein blocks viral infection and induces potent neutralizing antibody response
by: Zheng Liu, et al.
Published: (2022-10-01)

Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery
by: Xiaolin Yu, et al.
Published: (2021-12-01)

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
by: Daniel Junker, et al.
Published: (2022-05-01)

Moxifloxacin and Sulfamethoxazole-Based Nanocarriers Exhibit Potent Antibacterial Activities
by: Noor Akbar, et al.
Published: (2021-08-01)

Bio-mediated synthesis and characterisation of silver nanocarrier, and its potent anticancer action
by: Lee, Kar Xin, et al.
Published: (2019)

Bio-Mediated Synthesis and Characterisation of Silver Nanocarrier, and Its Potent Anticancer Action
by: Kar Xin Lee, et al.
Published: (2019-10-01)

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant
by: Cai He, et al.
Published: (2022-09-01)

A Toll-like Receptor-Activating, Self-Adjuvant Glycan Nanocarrier
by: Daping Xie, et al.
Published: (2022-05-01)

Modified hollow mesoporous silica nanoparticles as immune adjuvant-nanocarriers for photodynamically enhanced cancer immunotherapy
by: Qianru Li, et al.
Published: (2022-10-01)

Adjuvant Novel Nanocarrier-Based Targeted Therapy for Lung Cancer
by: Kangkan Sarma, et al.
Published: (2024-02-01)

Preparation and study of modified polyethyleneimine cationic adjuvant
by: Bai Lu, et al.
Published: (2023-01-01)

Multifunctional Protein Conjugates with Built-in Adjuvant (Adjuvant-Protein-Antigen) as Cancer Vaccines Boost Potent Immune Responses
by: Jing-Jing Du, et al.
Published: (2020-03-01)

Structure-based design of oligomeric receptor-binding domain (RBD) recombinant proteins as potent vaccine candidates against SARS-CoV-2
by: Ting Zhang, et al.
Published: (2023-01-01)

Screening of Efficient Adjuvants for the RBD-Based Subunit Vaccine of SARS-CoV-2
by: Juan Shi, et al.
Published: (2023-03-01)

The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
by: Yuhe Huang, et al.
Published: (2022-09-01)

Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity
by: Amir Ghaemi, et al.
Published: (2022-09-01)

Tag-Free SARS-CoV-2 Receptor Binding Domain (RBD), but Not C-Terminal Tagged SARS-CoV-2 RBD, Induces a Rapid and Potent Neutralizing Antibody Response
by: Ting-Wei Lin, et al.
Published: (2022-10-01)

Sequential immunization with SARS-CoV-2 RBD vaccine induces potent and broad neutralization against variants in mice
by: Shuo Song, et al.
Published: (2022-01-01)

Non-adjuvanted interferon-armed RBD protein nasal drops protect airway infection from SARS-CoV-2
by: Yifan Lin, et al.
Published: (2022-05-01)

Self-Assembled TLR7/8 Agonist-Mannose Conjugate as An Effective Vaccine Adjuvant for SARS-CoV-2 RBD Trimer
by: Changcai Teng, et al.
Published: (2022-12-01)